prof. dr. E. (Eelko) Hak

Full professor of Clinical Pharmacoepidemiology/Educational director Pharmacy-MPS

prof. dr. E. (Eelko) Hak
Telephone:
+31 50 36 38707 (Direct)
+31 50 36 37576 (Secretariat)
E-mail:
e.hak rug.nl

Research

Postal address:
A Deusinglaan1
Gebouw 3214, ruimte 0457
9713 AV
Groningen
Netherlands
Phone: +31 50 363 8707
  1. 2006
  2. Muller, L. M. A. J., Gorter, K. J., Hak, E., Goudzwaard, W. L., Schellevis, F. G., Hoepelman, I. M., & Rutten, G. E. H. M. (2006). Toegenomen risico op infecties bij patiënten met diabetes mellitus type 1 of 2. Nederlands Tijdschrift voor Geneeskunde, 150(10), 549-553.
  3. 2005
  4. Oosterheert, J. J., van Loon, A. M., Schuurman, R., Hoepelman, A. I. M., Hak, E., Thijsen, S., Nossent, G., Schneider, M. M. E., Hustinx, W. M. N., & Bonten, M. J. M. (2005). Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clinical Infectious Diseases, 41(10), 1438-1444. https://doi.org/10.1086/497134
  5. van den Berg, J. B., Hak, E., Vervoort, S. C. J. M., Hoepelman, I. M., Boucher, C. A. B., Schuurman, R., & Schneider, M. M. E. (2005). Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy. Hiv medicine, 6(5), 299-306. https://doi.org/10.1111/j.1468-1293.2005.00304.x
  6. Muller, L. M. A. J., Gorter, K. J., Hak, E., Goudzwaard, W. L., Schellevis, F. G., Hoepelman, A. I. M., & Rutten, G. E. H. M. (2005). Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical Infectious Diseases, 41(3), 281-288. https://doi.org/10.1086/431587
  7. 2004
  8. Van Essen, T., Hak, E., Verheij, T., Bueving, H., Thomas, S., Van Der Wouden, H., & Damoiseaux, R. (2004). Voorbarige conclusie over effectiviteit griepprik bij kinderen. Huisarts en Wetenschap, 47(13), 666-667.
  9. Oosterheert, J. J., Bonten, M. J. M., Hak, E., Lammers, J. W. J., Schneider, M. M. E., & Hoepelman, I. M. (2004). Toename van pneumoniegerelateerde ziekte en sterfte onder volwassenen in Nederland en mogelijke verklaringen daarvoor. Nederlands Tijdschrift voor de Geneeskunde, 148(36), 1765-1769.
  10. Tacken, M. A. J. B., Braspenning, J. C. C., Berende, A., Hak, E., De Bakker, D. H., Groenewegen, P. P., & Grol, R. P. T. M. (2004). Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine, 22(23-24), 2985-2992. https://doi.org/10.1016/j.vaccine.2004.02.017
  11. Matute, A. J., Hak, E., Schurink, C. A. M., McArthur, A., Alonso, E., Paniagua, M., Van Asbeck, E., Roskott, A. M., Froeling, F., Rozenberg-Arska, M., & Hoepelman, I. M. (2004). Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. International journal of antimicrobial agents, 23(5), 506-509. https://doi.org/10.1016/j.ijantimicag.2003.10.003
  12. 2003
  13. Hak, E., Bonten, M. J. M., & Hoes, A. W. (2003). Pneumococcal vaccination in older adults. New England Journal of Medicine, 349(7).
  14. Hirschmann, J. V., Hak, E., Bonten, M. J. M., Hoes, A. W., Marras, T. K., Fedson, D. S., Jackson, L. A., Neuzil, K. M., & Thompson, W. W. (2003). Pneumococcal vaccination in older adults [6] (multiple letters). New England Journal of Medicine, 349(7), 712-714. https://doi.org/10.1056/NEJMc031314
  15. Hak, E., Hoes, A. W., Grobbee, D. E., Lammers, J. W. J., van Essen, G. A., van Loon, A. M., & Verheij, T. J. M. (2003). Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. American Journal of Epidemiology, 157(8), 692-700.
  16. Hak, E., van Loon, S., Buskens, E., van Essen, G. A., de Bakker, D., Tacken, M. A. J. B., van Hout, B. A., Grobbee, D. E., & Verheij, T. J. M. (2003). Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study. Vaccine, 21(15), 1719-1724. https://doi.org/10.1016/S0264-410X(02)00520-0
  17. Rutten, F. H., Hak, E., Stalman, W. A. B., Verheij, T. J. M., & Hoes, A. W. (2003). Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment? Family practice, 20(1), 16-21.
  18. Terreehorst, I., Hak, E., Oosting, A. J., Tempels-Pavlica, Z., de Monchy, J. G. R., Bruijnzeel-Koomen, C. A. F. M., Aalberse, R. C., Gerth van Wijk, R., & Terreehorst, N. V. (2003). Evaluation of impermeable covers for bedding in patients with allergic rhinitis. New England Journal of Medicine, 349(3), 237 - 246.
  19. 2002
  20. Terreehorst, N. V., Oosting, AJ., Tempels-Pavlica, Z., de Monchy, JGR., Bruijnzeel-Koomen, CAFM., Hak, E., & van Wijk, R. (2002). Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clinical and Experimental Allergy, 32(8), 1160-1165.
  21. Smits, A. J., Hak, E., Stalman, W. A. B., van Essen, G. A., Hoes, A. W., & Verheij, T. J. M. (2002). Clinical effectiveness of conventional influenza vaccination in asthmatic children. Journal of hygiene, 128(2), 205-211. https://doi.org/10.1017/S0950268801006574
  22. Hak, E., Hoes, A. W., & Verheij, T. J. M. (2002). Influenza vaccinations: who needs them and when? DRUGS, 62(17), 2413-2420.
  23. 2001
  24. Hak, E., Moons, K. G., Verheij, T. J., & Hoes, A. W. (2001). Clinical signs and symptoms predicting influenza infection. Archives of Internal Medicine, 161(10), 1351-1352.
  25. Hak, E., Verheij, T. J., van Essen, G. A., Lafeber, A. B., Grobbee, D. E., & Hoes, A. W. (2001). Prognostic factors for influenza-associated hospitalization and death during an epidemic. Journal of hygiene, 126(2), 261-268. https://doi.org/10.1017/S0950268801005180
  26. 2000
  27. Hak, E., Hermens, R. P., Hoes, A. W., Verheij, T. J., Kuyvenhoven, M. M., & van Essen, G. A. (2000). Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scandinavian Journal of Primary Health Care, 18(4), 237-241.
  28. Hak, E., Grobbee, D. E., Van Essen, G. A., Buskens, E., Verheij, T. J. M., Nichol, K. L., Baken, L., Wuorenma, J., & Nelson, A. (2000). Pneumococcal vaccination of the elderly: Do we need another trial? [2] (multiple letters). Archives of Internal Medicine, 160(11), 1698-1699.
  29. Hak, E., Grobbee, D. E., van Essen, G. A., Buskens, E., & Verheij, T. J. (2000). Pneumococcal vaccination of the elderly: do we need another trial? Archives of Internal Medicine, 160(11), 1698-9.
  30. 1999
  31. Hermens, R. P., Hak, E., Hulscher, M. E., Mulder, J., Tacken, M. A., Braspenning, J. C., & Grol, R. P. (1999). Improving population-based cervical cancer screening in general practice: effects of a national strategy. International Journal for Quality in Health Care, 11(3), 193-200.
  32. Van Der Graaf, Y., Akkersdijk, G. J. M., Hak, E., Godaert, G. L. R., & Eikelboom, B. C. (1999). Verhoogde prevalentie van aneurysma aortae abdominalis bij broers van patienten met een dergelijk aneurysma. Nederlands Tijdschrift voor Geneeskunde, 143(9), 471-474.
  33. 1998
  34. Hak, E., Van Essen, G. A., Grobbee, D. E., Buskens, E., Hoepelman, I. M., & Verheij, T. J. M. (1998). Hoe doelmatig is pneumokokkenvaccinatie in de huisartspraktijk? Een systematisch literatuuronderzoek. Huisarts en Wetenschap, 41(10), 470-475.
  35. Akkersdijk, G. J., van der Graaf, Y., Moll, F. L., de Vries, A. C., Kitslaar, P. J., van Bockel, J. H., Hak, E., & Eikelboom, B. C. (1998). Complications of standard elective abdominal aortic aneurysm repair. European Journal of Vascular and Endovascular Surgery, 15(6), 505-510.
  36. Hak, E., van Essen, G. A., Grobbee, D. E., & Verheij, T. J. (1998). Effectiveness of pneumococcal vaccine. The Lancet, 351(9111).
Previous 1...3 4 5 6 7 8 Next

ID: 347541